type here...

CATEGORIES

Press Release

LATEST

1...789...12Page 8 of 12

TRENDING

EDITORS CHOICE

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Medika Life -
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

Medika Life -
The flawed design of the New York Health Act would be felt most acutely by low-income New Yorkers, a new FREOPP study finds. This Single-Payer Health

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Coronavirus: FDA Authorizes First Point-of-Care Antibody Test

Medika Life -
The Assure COVID-19 IgG/IgM Rapid Test Device is currently the only FDA authorized COVID-19 POC serology test and is available by prescription only.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories